Amylyx Pharmaceuticals Inc (AMLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 0 | 0 | 285 | 0 | 0 |
| Gross Profit | N/A | 0 | 285 | N/A | N/A |
| Operating Expenses | 47,814 | 28,315 | 23,203 | 18,587 | 12,868 |
| Operating Income | -47,814 | -28,315 | -22,918 | -18,587 | -12,868 |
| Other Income | 112 | -29 | -224 | -3,335 | -1,655 |
| Pre-tax Income | -47,702 | -28,344 | -23,142 | -21,922 | -14,523 |
| Income Tax | 146 | 0 | N/A | N/A | N/A |
| Net Income Continuous | -47,848 | -28,344 | -23,142 | -21,922 | -14,523 |
| Net Income | $-47,848 | $-28,344 | $-23,142 | $-21,922 | $-14,523 |
| EPS Basic Total Ops | -0.93 | -4.19 | -3.42 | -3.41 | -2.33 |
| EPS Basic Continuous Ops | -0.93 | -4.19 | -3.42 | -3.41 | -2.33 |
| EPS Diluted Total Ops | -0.93 | -4.19 | -3.42 | -3.41 | -2.33 |
| EPS Diluted Continuous Ops | -0.93 | -4.19 | -3.42 | -3.41 | -2.33 |
| EBITDA(a) | $-47,777 | $-28,195 | $-22,885 | $-18,577 | $-12,858 |